Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer

Conclusions Our results indicate that aberrant SOX11 gene promoter methylation may underlie its down-regulation in GC. SOX11 gene promoter hyper-methylation may serve as a biomarker to predict the clinical outcome of GC.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research